OSR1 significantly negatively regulated SLC6A8 activity. OSR1 again decreased significantly maximal transport rate. Conclusions: Both, SPAK and OSR1, are negative regulators of the creatine transporter SLC6A8.
Introduction
With-no-K[Lys] kinases (WNK) [1] [2] [3] [4] [5] and their downstream kinases SPS1-related proline/alanine-rich kinase (SPAK) [1, 6, 7] and oxidative stress-responsive kinase 1 (OSR1) [8, 9] participate in the regulation of transport and blood pressure [10] [11] [12] [13] [14] . Both, SPAK and [24] . Genetic defects affecting the activity of WNK kinases may lead to Gordon's syndrome, a monogenic disorder characterized by hyperkalaemia and hypertension [4, 5, 25, 26] . SPAK/OSR1 participates in a wide variety of further functions including neuroexcitability [27] [28] [29] .
To the best of our knowledge, nothing is known about effects of WNK, SPAK and/or OSR1 on the activity of the creatine transporter CreaT (SLC6A8), a member of the superfamily of Na + ,Cl -coupled transporters for neurotransmitters [30] [31] [32] and organic osmolytes [33, 34] . SLC6A8 is expressed in a wide variety of tissues, such as kidney, small intestine, heart, skeletal muscle, brain and retina [35] [36] [37] [38] . Genetic disorders affecting SLC6A8 lead to mental retardation with seizures [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] .
In order to test whether SPAK or OSR1 may influence SLC6A8 activity, cRNA encoding SLC6A8 was injected into Xenopus laevis oocytes without or with additional injection of cRNA encoding SPAK or OSR1. The creatine induced current was determined utilizing dual electrode voltage clamp. OSR1 [57] were used for generation of cRNA as described previously [58, 59] . The constructs were a kind gift from Dario Alessi (University of Dundee).
Materials and Methods

Ethical Statement
Voltage clamp in Xenopus laevis oocytes
Xenopus laevis oocytes were prepared as previously described [60, 61] . 15 ng cRNA encoding SLC6A8 and 10 ng of cRNA encoding wild-type, constitutively active, WNK insensitive or inactive kinase of either SPAK or OSR1 were injected on the same day after preparation of the oocytes. The oocytes were stored at 17°C in incubation medium ND96, a solution containing 88.5 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM NaOH and 5 mM sodium pyruvate (C 3 H 3 NaO 3 ), supplemented with 100 mg/l Gentamycin, 50 mg/l Tetracycline, 1.6 mg/l Ciprofloxacin and 90 mg/l Theophiline (pH 7.4). [62, 63] . Solutions were sterilized through 0.22 µm filter. The voltage clamp experiments were performed at room temperature 4 days after the first injection [64, 65] . Carrier activity was estimated from substrate (1 mM creatine) induced current at a holding potential of -60 mV [66] . The data were filtered at 10 Hz and recorded with a Digidata A/D-D/A converter (1322A Axon Instruments) and Clampex 9.2 software for data acquisition and analysis (Axon Instruments) [67] [68] [69] . The oocytes recording chamber was continuously perfused with control ND96 solution containing (in mM): 93.5 NaCl, 2 KCl, 1.8 CaCl 2 , 1 MgCl 2, 5 HEPES, 2.5 NaOH (pH 7.4). The flow rate of the superfusion was approx. 20 ml/min, and a complete exchange of the bath solution was reached within about 10 s [70] [71] [72] . For kinetic analysis the creatine induced-current (I creat ) was plotted against the respective creatine concentration (s) and maximal current (I max ) as well as concentration required for halfmaximal current (k m ) calculated using the equation I CreaT = I max •s/(k m + s).
Statistical analysis
Data are provided as means ± SEM, n represents the number of oocytes investigated [73] . All voltage clamp experiments were repeated with at least 3 batches of oocytes; in all repetitions qualitatively similar data were obtained. Data were tested for significance using ANOVA or t-test, as appropriate. Results with p < 0.05 were considered statistically significant. 
Results
The present study explored whether SPAK (SPS1-related proline/alanine-rich kinase) and/or OSR1 (oxidative stress-responsive kinase 1) are able to modify the function of the creatine transporter CreaT (SLC6A8). To this end, cRNA encoding SLC6A8 was injected into Xenopus laevis oocytes with or without additional injection of cRNA encoding wildtype SPAK, mutant SPAK, wild-type OSR1 or mutant OSR1. Creatine induced-current (I creat ) was determined utilizing dual electrode voltage clamp. As shown in Fig. 1 , no appreciable current was observed in water-injected oocytes indicating that the oocytes did not express significant endogenous electrogenic creatine transport. Creatine exposure of SLC6A8 expressing oocytes was, however followed by a sizable I creat . The additional coexpression of wild-type SPAK significantly decreased the I creat in SLC6A8 expressing Xenopus laevis oocytes.
In order to determine whether SPAK coexpression modifies the maximal I creat or the affinity of the carrier, Xenopus laevis oocytes expressing SLC6A8 without or with additional expression of SPAK were exposed to creatine at concentrations ranging from 3 µM to 2 mM. As illustrated in Fig. 2 , the I creat was a function of the extracellular creatine concentration. Kinetic analysis revealed that the maximal creatine induced current was significantly (p<0.01) higher in Xenopus laevis oocytes expressing SLC6A8 alone (18.4 ± 2.6 nA, n = 6-8) than in Xenopus laevis oocytes expressing SLC6A8 together with SPAK (7.6 ± 1.0 nA, n = 6-7). The concentration required for halfmaximal creatine induced current was highly variable and not significantly different between Xenopus laevis oocytes expressing SLC6A8 alone (192 ± 102 mM, n = 6-8) and Xenopus laevis oocytes expressing SLC6A8 together with SPAK (29 ± 22 mM, n = 6-7).
Further experiments explored the effect of SPAK mutants on the I creat in SLC6A8 expressing Xenopus laevis oocytes. To this end the SPAK mutants were coexpressed in SLC6A8 expressing Xenopus oocytes. As illustrated in Fig. 3 , the effect of wild-type SPAK was Further experiments addressed the effect of OSR1 on SLC6A8 activity. As shown in Fig.  4 , the additional coexpression of wild-type OSR1 significantly decreased the I creat in SLC6A8 expressing Xenopus laevis oocytes. Fezai/Elvira/Borras/Ben-Attia/Hoseinzadeh/Lang: SPAK/OSR1 Negatively Regulate CreaT with OSR1. Kinetic analysis revealed that the maximal I creat was significantly (p<0.001) higher in Xenopus laevis oocytes expressing SLC6A8 alone (23.9 ± 2.1 nA, n = 5-6) than in Xenopus laevis oocytes expressing SLC6A8 together with OSR1 (8.2 ± 0.7 nA, n = 7). The concentration required for halfmaximal creatine induced current was significantly higher in Xenopus oocytes expressing SLC6A8 alone (152 ± 53 mM, n = 5-6) than in Xenopus oocytes expressing SLC6A8 together with OSR1 (26 ± 14 mM, n = 7) (p<0.05).
As illustrated in Fig. 6 , the effect of wild-type OSR1 was mimicked by constitutively active OSR1.
Discussion
The present study discloses a novel function of SPAK and OSR1, i.e. the negative regulation of the creatine transporter SLC6A8. Coexpression of SPAK or OSR1 is followed by a decrease of the maximal creatine transport in SLC6A8 expressing oocytes. Transporters similarly negatively regulated by SPAK and OSR1 include KCl cotransporters [27, 74] . On the other hand SPAK and OSR1 positively regulate the Na + ,Cl -(NCC) and Na
-(NKCC) cotransporters [2, 3, [8] [9] [10] [15] [16] [17] [18] [19] [20] [21] [22] [23] as well as Na + coupled phosphate transport [24] . The molecular requirements for negative or positive regulation by SPAK and OSR1 are incompletely understood.
The effect of wild type SPAK and OSR1 on SLC6A8 activity was mimicked by the constitutively active mutants. SLC6A8 activity was not affected by the kinase dead mutants, indicating that functional kinases are required for the SPAK/OSR1 sensitive regulation of SLC6A8. SLC6A8 activity tended to be decreased by the WNK insensitive T233A SPAK mutant and was significantly decreased by the WNK insensitive T185A OSR1 mutant. Those observations could point to some WNK independent activity of SPAK and/or OSR1. The observations do not necessarily indicate that the carrier is directly phosphorylated by the kinases. Instead, the kinases could phosphorylate and thus modify the function of other signaling molecules involved in the regulation of the carrier.
The present study did not address the in vivo significance of SPAK/OSR1 sensitive creatine transport activity. The carrier plays an important role in the regulation of neuronal function and neuroexcitability [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] . The WNK-SPAK/OSR1 kinase pathway is similarly Fezai/Elvira/Borras/Ben-Attia/Hoseinzadeh/Lang: SPAK/OSR1 Negatively Regulate CreaT involved in the regulation of neuronal excitation [27, 74] . SPAK/OSR1 modify, however, neuroexcitability at least in part by activation of NKCC dependent Cl -uptake and inhibition of KCC dependent Cl -exit leading to increase of intracellular chloride concentration [27, 74] . The intracellular Cl -concentration is in turn a critical determinant of the effects of GABA on cell membrane potential and neuronal excitation [27, 74] . WNK kinases are activated following decrease of intracellular Cl -concentration and they trigger cellular Cl -uptake by activating SPAK/OSR1 [27] . Disorders involving deranged SPAK/OSR activity include arterial hypertension and enhanced neuronal activity leading to epilepsy, spasticity, neuropathic pain, schizophrenia, and autism [27] .
SPAK/OSR1 further contribute to cell volume regulation by triggering cellular NaCl uptake due to activation of the Na . We do not know, whether SLC6A8 is regulated by cell volume. The SLC6A8 related organic osmolyte transporters are up-regulated rather than negatively regulated by cell shrinkage [33, 34] .
Conclusion
SPAK and OSR1 are capable to negatively regulate the creatine transporter SLC6A8.
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